Urology Times October 17, 2023
Staff

“Hopefully this law will allow more patients with advanced prostate cancer to gain access to these medications, and to take it without substantially changing the quality of their life when it comes to financial consequences,” says Benjamin Pockros, MD.

In this video, Benjamin Pockros, MD, highlights take-home messages from the publication, “Impact of the Inflation Reduction Act for patients with advanced prostate cancer,” for which he served as the lead author. Pockros is a urology resident at the University of Michigan in Ann Arbor, Michigan.

Video Transcript:

What were the key take-home messages from this work?

Our work focuses on prostate cancer in this country. In recent years, there’s been a development of oral targeted therapies, which has been great....

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Conferences / Podcast, Insurance, Medicare, Patient / Consumer, Pharma, Pharma / Biotech, Provider, Trends
Achieving Value-Based Care Through the Payvider Model
208 million Americans are classified as obese or overweight, according to new study on 132 data sources
Epic's new interoperability push, explained
How 3 Health Systems Are Scaling Hybrid & Home-Based Models
CMS finalizes new kidney transplant model: 10 things to know

Share This Article